Larvol Delta - NXP800101-A-Phase-1-Clinical-Study-of-NXP800-in-Subjects-With-Advanced-Cancers-and-Expansion-in-Subjects-With-Ovarian-Cancer

NXP800 - Nuvectis Pharma

http://clinicaltrials.gov/ct2/show/NCT05226507

Aug 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next